• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于完全似然的灵活自适应套索 Cox 脆弱性模型

A Flexible Adaptive Lasso Cox Frailty Model Based on the Full Likelihood.

机构信息

Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.

Statistical Methods for Big Data, TU Dortmund University, Dortmund, Germany.

出版信息

Biom J. 2024 Oct;66(7):e202300020. doi: 10.1002/bimj.202300020.

DOI:10.1002/bimj.202300020
PMID:39377272
Abstract

In this work, a method to regularize Cox frailty models is proposed that accommodates time-varying covariates and time-varying coefficients and is based on the full likelihood instead of the partial likelihood. A particular advantage of this framework is that the baseline hazard can be explicitly modeled in a smooth, semiparametric way, for example, via P-splines. Regularization for variable selection is performed via a lasso penalty and via group lasso for categorical variables while a second penalty regularizes wiggliness of smooth estimates of time-varying coefficients and the baseline hazard. Additionally, adaptive weights are included to stabilize the estimation. The method is implemented in the R function coxlasso, which is now integrated into the package PenCoxFrail, and will be compared to other packages for regularized Cox regression.

摘要

在这项工作中,提出了一种正则化 Cox 脆弱性模型的方法,该方法同时适用于时变协变量和时变系数,并且基于完全似然而不是部分似然。这种框架的一个特别优点是可以以平滑的半参数方式明确地对基线风险进行建模,例如,通过 P-样条。通过lasso 惩罚和分类变量的组lasso 进行变量选择的正则化,同时第二个惩罚正则化时变系数和基线风险的平滑估计的不规则性。此外,还包含自适应权重以稳定估计。该方法在 R 函数 coxlasso 中实现,该函数现在已集成到 PenCoxFrail 包中,并将与其他用于正则化 Cox 回归的包进行比较。

相似文献

1
A Flexible Adaptive Lasso Cox Frailty Model Based on the Full Likelihood.基于完全似然的灵活自适应套索 Cox 脆弱性模型
Biom J. 2024 Oct;66(7):e202300020. doi: 10.1002/bimj.202300020.
2
A flexible class of generalized joint frailty models for the analysis of survival endpoints.用于生存终点分析的一类灵活的广义联合脆弱模型。
Stat Med. 2023 Apr 15;42(8):1233-1262. doi: 10.1002/sim.9667. Epub 2023 Feb 12.
3
Variable selection in subdistribution hazard frailty models with competing risks data.具有竞争风险数据的子分布风险脆弱性模型中的变量选择
Stat Med. 2014 Nov 20;33(26):4590-604. doi: 10.1002/sim.6257. Epub 2014 Jul 10.
4
A double-Cox model for non-proportional hazards survival analysis with frailty.具有脆弱性的非比例风险生存分析的双 Cox 模型。
Stat Med. 2023 Aug 15;42(18):3114-3127. doi: 10.1002/sim.9760. Epub 2023 May 15.
5
Model selection for Cox models with time-varying coefficients.具有时变系数的Cox模型的模型选择
Biometrics. 2012 Jun;68(2):419-28. doi: 10.1111/j.1541-0420.2011.01692.x. Epub 2012 Apr 16.
6
Selection of effects in Cox frailty models by regularization methods.通过正则化方法在Cox脆弱模型中选择效应
Biometrics. 2017 Sep;73(3):846-856. doi: 10.1111/biom.12637. Epub 2017 Jan 13.
7
Fast Lasso method for large-scale and ultrahigh-dimensional Cox model with applications to UK Biobank.快速套索法在大规模超高维 Cox 模型中的应用:以 UK Biobank 为例。
Biostatistics. 2022 Apr 13;23(2):522-540. doi: 10.1093/biostatistics/kxaa038.
8
Posterior likelihood methods for multivariate survival data.多变量生存数据的后验似然方法。
Biometrics. 1998 Dec;54(4):1463-74.
9
Penalized variable selection for cause-specific hazard frailty models with clustered competing-risks data.基于聚类竞争风险数据的有向风险脆弱性模型的惩罚变量选择。
Stat Med. 2021 Dec 20;40(29):6541-6557. doi: 10.1002/sim.9197. Epub 2021 Sep 20.
10
A flexible approach to the crossing hazards problem.灵活处理交叉危险问题的方法。
Stat Med. 2010 Aug 15;29(18):1947-57. doi: 10.1002/sim.3959.

引用本文的文献

1
Explore potential immune-related targets of leeches in the treatment of type 2 diabetes based on network pharmacology and machine learning.基于网络药理学和机器学习探索水蛭治疗2型糖尿病的潜在免疫相关靶点。
Front Genet. 2025 Apr 14;16:1554622. doi: 10.3389/fgene.2025.1554622. eCollection 2025.
2
Biomarkers in glioblastoma and degenerative CNS diseases: defining new advances in clinical usefulness and therapeutic molecular target.胶质母细胞瘤和中枢神经系统退行性疾病中的生物标志物:临床应用和治疗分子靶点的新进展
Front Mol Biosci. 2025 Mar 18;12:1506961. doi: 10.3389/fmolb.2025.1506961. eCollection 2025.